<DOC>
	<DOCNO>NCT01706627</DOCNO>
	<brief_summary>Meta-analysis previous study show melatonin beneficial adjutant reduce chemotherapy-induced toxicity ; however randomize , double-blind , placebo control trial conduct . This study evaluate effect melatonin improve quality life reduce chemotherapy-induced toxicity advance cancer patient . This multi-center , randomize , double-blind , placebo control trial conduct patient histologically proven advanced non small cell lung , breast , head neck sarcoma cancer . Mixed-block randomization , stratify center treatment scheme use divide eligible patient three group : melatonin 20 mg , 10 mg match placebo . The patient require take studied drug night ( 21.00 pm ) first day chemotherapy continue daily six month . Standard treatment chemotherapy accord center 's standard protocol . Study endpoint QOL ( FACT ) , adverse event frequency ( CTCAE ) , oxidative stress status , melatonin level , survival .</brief_summary>
	<brief_title>Melatonin In Reduction Chemotherapy-Induced Toxicity ( MIRCIT ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Melatonin</mesh_term>
	<criteria>histologically proven advanced NSCLC , breast , head neck , sarcoma cancer Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) ≤ 2 platelet count ≥100,000 cells/mm3 white blood cell count ≥ 3,000 cell/mm3 hemoglobin ≥ 10 g/dL serum creatinine ≤ 1.5 mg/dL bilirubin ≤ 2 mg/dL AST ≤ 2.5 time upper limit normal ( ULN ) subject without metastasis AST ≤ 2.5 time UNL liver metastases New York Heart Association grade ≤ 2 write consent Patients receive prior chemotherapy biotherapy , radiotherapy surgery within 1 month precede randomization Patients one type cancer brain metastasis exclude trial . Patients moderate neuropathy ( CTCAE grade ≥ 2 ) Patients active infection , uncontrolled complication ( i.e . blood glucose &gt; 200 mg/dL , uncontrolled hypertension , unstable angina , history congestive heart failure history myocardial infarction within one year ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>cancer</keyword>
	<keyword>melatonin</keyword>
	<keyword>adjuvant therapy</keyword>
	<keyword>quality life</keyword>
	<keyword>survival</keyword>
	<keyword>adverse event</keyword>
	<keyword>oxidative stress</keyword>
</DOC>